Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MOREStril
- Development stage
- Preclinical
- Lead developer
- Farmaceutici Damor
- Modality
- Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
MOREStril (AKP04) is a multi-ingredient nutraceutical supplement developed by Damor Farmaceutici and its subsidiary Akademy Pharma for the management of menopause-related symptoms. The formulation combines plant-based extracts, including soy and angelica (*Angelica sinensis*), which provide phytoestrogens to help alleviate menopausal disorders, with the probiotic strain *Bifidobacterium breve* to support intestinal flora balance. Additionally, it contains *Morus alba* (white mulberry) extract to assist in carbohydrate metabolism and fluid drainage, and magnesium to support bone health. It is positioned as a natural alternative or adjunct for women experiencing the physiological transitions of menopause.
- Brand names
- MOREStril
- Other names
- AKP04AKP-04AKP 04
02
Targets
ER (Estrogen receptor)
Beyond the preview
Go deeper on MOREStril.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MOREStril.